CD4 CTLs are a CD4 subset with cytotoxic activity and can directly kill tumor cells by secreting granzyme B and perforin, while Th2 and Th17 cells inhibit cell-mediated immunity and promote tumor progression [53,54,55,56]. The gene discussed is PRF1; the disease is neoplasm.